Skip to main content

Avanos Medical, Inc. (AVNS)

NYSE: AVNS · IEX Real-Time Price · USD
29.74 -0.72 (-2.36%)
Dec 3, 2021 3:59 PM EST - Market closed

Total Valuation

Avanos Medical has a market cap or net worth of $1.43 billion. The enterprise value is $1.54 billion.

Market Cap1.43B
Enterprise Value1.54B

Important Dates

The latest earnings date was Tuesday, November 2, 2021 before market open.

Last Earnings DateNov 2, 2021
Ex-Dividend Daten/a

Share Statistics

Avanos Medical has 48.19 million shares outstanding. The number of shares has increased by 0.61% in one year.

Shares Outstanding48.19M
Shares Change (YoY)+0.61%
Shares Change (QoQ)+0.11%
Owned by Insiders (%)1.05%
Owned by Institutions (%)92.27%
Float45.17M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio1.95
PB Ratio1.14
P/FCF Ratio96.18
PEG Ration/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of 103.43.

EV / Earningsn/a
EV / Sales2.09
EV / EBITDAn/a
EV / EBITn/a
EV / FCF103.43

Financial Position

The company has a current ratio of 3.14, with a Debt / Equity ratio of 0.16.

Current Ratio3.14
Quick Ratio1.67
Debt / Equity0.16
Debt / EBITDA-9.80
Debt / FCF13.81

Financial Efficiency

Return on Equity (ROE)-4.10%
Return on Assets (ROA)-3.20%
Return on Capital (ROIC)-9.00%
Revenue Per Employee$136,840
Profits Per Employee-$9,665
Employee Count5,380
Asset Turnover0.45
Inventory Turnover2.22

Taxes

Income Tax-13.90M
Effective Tax Rate21.09%

Stock Price Statistics

. The beta is 0.87, so Avanos Medical's price volatility has been lower than the market average.

Beta (1Y)0.87
52-Week Price Changen/a
50-Day Moving Average32.69
200-Day Moving Average34.75
Average Volume (30 Days)286,119

Short Selling Information

Short Interest1.29M
Short % of Shares Out2.67%
Short % of Float2.85%
Short Ratio (days to cover)4.55

Income Statement

In the last 12 months, Avanos Medical had revenue of $736.20 million and -$52.00 million in losses. Earnings per share was -$1.09.

Revenue736.20M
Gross Profit356.30M
Operating Income14.70M
Pretax Income-65.90M
Net Income-52.00M
EBITDA-21.00M
EBIT-60.60M
Earnings Per Share (EPS)-$1.09
Full Income Statement

Balance Sheet

The company has $97.80 million in cash and $205.80 million in debt, giving a net cash position of -$108.00 million or -$2.24 per share.

Cash & Cash Equivalents97.80M
Total Debt205.80M
Net Cash-108.00M
Net Cash Per Share-$2.24
Book Value1.26B
Book Value Per Share26.19
Working Capital275.80M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $36.30 million and capital expenditures -$21.40 million, giving a free cash flow of $14.90 million.

Operating Cash Flow36.30M
Capital Expenditures-21.40M
Free Cash Flow14.90M
FCF Per Share$0.31
Full Cash Flow Statement

Margins

Gross margin is 48.40%, with operating and profit margins of 2.00% and -7.06%.

Gross Margin48.40%
Operating Margin2.00%
Pretax Margin-8.95%
Profit Margin-7.06%
EBITDA Margin-2.85%
EBIT Margin-8.23%
FCF Margin2.02%

Dividends & Yields

Avanos Medical does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-3.63%
FCF Yield1.04%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a